Market Cap 31.31M
Revenue (ttm) 1.03M
Net Income (ttm) -13.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,300.97%
Debt to Equity Ratio 0.00
Volume 67,150
Avg Vol 434,692
Day's Range N/A - N/A
Shares Out 14.98M
Stochastic %K 36%
Beta 1.03
Analysts Strong Sell
Price Target $10.25

Company Profile

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual aro...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 926 7655
Address:
3655 Nobel Drive, Suite 260, San Diego, United States
VirtualInvestor
VirtualInvestor Jul. 14 at 7:39 PM
$DARE - Starting Soon! #DARE is about to go live during the #VirtualInvestor Closing Bell event. Hear CEO Sabrina Martucci Johnson discuss Flora Sync LF5™, the Company's strategy and future milestones, then take part in the live Q&A. Watch: https://us02web.zoom.us/webinar/register/WN_zsqyRYegSCaku_o0u3frlg#/registration
0 · Reply
VirtualInvestor
VirtualInvestor Jul. 14 at 6:08 PM
$DARE - 🔔 Tune In Today at 4 PM ET! CEO Sabrina Martucci Johnson goes live today to discuss $DARES commercial strategy and what's ahead. Stay for the live Q&A during today's #VirtualInvestor Closing Bell event. Watch here: https://us02web.zoom.us/webinar/register/WN_zsqyRYegSCaku_o0u3frlg#/registration
0 · Reply
VirtualInvestor
VirtualInvestor Jul. 13 at 8:06 PM
$DARE - Happening Tomorrow at 4 PM ET Join Daré CEO Sabrina Martucci Johnson for a Virtual Investor Closing Bell to hear about the launch of FloraSync LF5, commercial strategy, upcoming catalysts and growth plans. Register Here: https://us02web.zoom.us/webinar/register/WN_zsqyRYegSCaku_o0u3frlg#/registration
1 · Reply
SwingTraderPro1
SwingTraderPro1 Jul. 11 at 2:33 PM
Some of the biggest lessons in growth investing come from the winners you sold too early. Looking back: $AXTI - exited around $1.50 $ASYS - exited around $5 $NVTS - exited around $4 Nobody knows which small caps will become the next multibaggers until the market proves it. Now the focus shifts forward. Watching opportunities like: $DARE $SKYX Corrections often create the best setups -when fear replaces hype and quality companies become mispriced. The hunt for the next breakout opportunity continues.
0 · Reply
HMIC
HMIC Jul. 10 at 8:51 AM
1 · Reply
HMIC
HMIC Jul. 5 at 1:35 PM
$DARE Heavy insider trading.
2 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 2 at 10:03 AM
$DARE do your due dill
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 2 at 10:02 AM
$DARE yep
1 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 2 at 10:02 AM
$DARE 👍
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 2 at 10:02 AM
$DARE target here?
0 · Reply
Latest News on DARE
Daré Bioscience Transcript: Virtual Investor Closing Bell

Jul 14, 2026, 4:00 PM EDT - 23 hours ago

Daré Bioscience Transcript: Virtual Investor Closing Bell


Daré Bioscience Transcript: AGM 2026

Jun 11, 2026, 12:00 PM EDT - 4 weeks ago

Daré Bioscience Transcript: AGM 2026


Daré Bioscience Proxy statement: Proxy filing

Jun 1, 2026, 8:00 AM EDT - 6 weeks ago

Daré Bioscience Proxy statement: Proxy filing


Daré Bioscience Proxy statement: Proxy filing

Jun 1, 2026, 8:00 AM EDT - 6 weeks ago

Daré Bioscience Proxy statement: Proxy filing


Dare Bioscience initiates DARE-HPV clinical study

2026-05-18T12:14:40.000Z - 2 months ago

Dare Bioscience initiates DARE-HPV clinical study


Daré Bioscience Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Daré Bioscience Earnings Call Transcript: Q1 2026


Daré Bioscience Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Daré Bioscience Quarterly report: Q1 2026


Daré Bioscience Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Daré Bioscience Earnings release: Q1 2026


Daré Bioscience Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Daré Bioscience Proxy statement: Proxy filing


Daré Bioscience Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Daré Bioscience Proxy statement: Proxy filing


Daré Bioscience Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 3 months ago

Daré Bioscience Proxy statement: Proxy filing


Daré Bioscience Earnings Call Transcript: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 3 months ago

Daré Bioscience Earnings Call Transcript: Q4 2025


Daré Bioscience Annual report: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 3 months ago

Daré Bioscience Annual report: Q4 2025


Daré Bioscience Earnings release: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 3 months ago

Daré Bioscience Earnings release: Q4 2025


Daré Bioscience Slides: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 3 months ago

Daré Bioscience Slides: Q4 2025


On National Viagra Day, Women Finally Claim Their Turn:

Mar 23, 2026, 8:00 AM EDT - 4 months ago

On National Viagra Day, Women Finally Claim Their Turn:


Dare Bioscience receives NIH funding award notice for DARE-PTB1

2026-03-16T12:39:51.000Z - 4 months ago

Dare Bioscience receives NIH funding award notice for DARE-PTB1


Dare Bioscience announces return of rights to Oveprene

2025-12-01T13:20:39.000Z - 8 months ago

Dare Bioscience announces return of rights to Oveprene


Dare Bioscience receives $3.6M in additional grant funding

2025-11-24T13:30:31.000Z - 8 months ago

Dare Bioscience receives $3.6M in additional grant funding


Daré Bioscience Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Daré Bioscience Earnings Call Transcript: Q3 2025


Daré Bioscience Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Daré Bioscience Quarterly report: Q3 2025


Daré Bioscience Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Daré Bioscience Earnings release: Q3 2025


Dare Bioscience to host webinar on the DARE to PLAY

2025-11-11T13:10:31.000Z - 8 months ago

Dare Bioscience to host webinar on the DARE to PLAY


Dare Bioscience receives $4M non-dilutive grant installment

2025-10-06T12:20:36.000Z - 10 months ago

Dare Bioscience receives $4M non-dilutive grant installment


Dare Bioscience upgraded to Buy from Hold at Maxim

2025-09-04T11:45:08.000Z - 11 months ago

Dare Bioscience upgraded to Buy from Hold at Maxim


Daré Bioscience Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Daré Bioscience Earnings Call Transcript: Q2 2025


Daré Bioscience Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Daré Bioscience Quarterly report: Q2 2025


Daré Bioscience Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Daré Bioscience Earnings release: Q2 2025


Dare Bioscience to host webinar on Sildenafil cream

2025-07-21T12:27:31.000Z - 1 year ago

Dare Bioscience to host webinar on Sildenafil cream


Why Is Daré Bioscience Stock (DARE) Up 240% Today?

2025-07-15T00:37:00.000Z - 1 year ago

Why Is Daré Bioscience Stock (DARE) Up 240% Today?


Daré Bioscience Proxy statement: Proxy Filing

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Daré Bioscience Proxy statement: Proxy Filing


Daré Bioscience Slides: Corporate Presentation

Jun 9, 2025, 7:00 AM EDT - 1 year ago

Daré Bioscience Slides: Corporate Presentation


Daré Bioscience Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Daré Bioscience Earnings Call Transcript: Q1 2025


Daré Bioscience Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Daré Bioscience Quarterly report: Q1 2025


Daré Bioscience Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Daré Bioscience Earnings release: Q1 2025


Daré Bioscience Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Daré Bioscience Proxy statement: Proxy Filing


Daré Bioscience Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Daré Bioscience Proxy statement: Proxy Filing


Daré Bioscience Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Daré Bioscience Earnings Call Transcript: Q4 2024


Daré Bioscience Earnings release: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Daré Bioscience Earnings release: Q4 2024


Daré Bioscience Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Daré Bioscience Annual report: Q4 2024


Daré Bioscience Registration statement: Registration Filing

Nov 15, 2024, 7:00 AM EST - 1 year ago

Daré Bioscience Registration statement: Registration Filing


Daré Bioscience Earnings Call Transcript: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Daré Bioscience Earnings Call Transcript: Q3 2024


Daré Bioscience Earnings release: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Daré Bioscience Earnings release: Q3 2024


Daré Bioscience Quarterly report: Q3 2024

Nov 14, 2024, 4:30 PM EST - 1 year ago

Daré Bioscience Quarterly report: Q3 2024


Daré Bioscience Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Earnings Call Transcript: Q2 2024


Daré Bioscience Quarterly report: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Quarterly report: Q2 2024


Daré Bioscience Earnings release: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Earnings release: Q2 2024


Daré Bioscience Announces Reverse Stock Split

Jun 27, 2024, 8:00 AM EDT - 2 years ago

Daré Bioscience Announces Reverse Stock Split


Daré Bioscience Earnings Call Transcript: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Earnings Call Transcript: Q1 2024


Daré Bioscience Quarterly report: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Quarterly report: Q1 2024


Daré Bioscience Earnings release: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Earnings release: Q1 2024


Daré Bioscience Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Daré Bioscience Proxy statement: Proxy Filing


Daré Bioscience Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Daré Bioscience Proxy statement: Proxy Filing


Daré Bioscience Proxy statement: Proxy Filing

Apr 16, 2024, 8:00 AM EDT - 2 years ago

Daré Bioscience Proxy statement: Proxy Filing


Daré Bioscience Registration statement: Registration Filing

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Daré Bioscience Registration statement: Registration Filing


Daré Bioscience Registration statement: Registration Filing

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Daré Bioscience Registration statement: Registration Filing


Daré Bioscience Earnings Call Transcript: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Earnings Call Transcript: Q4 2023


Daré Bioscience Annual report: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Annual report: Q4 2023


Daré Bioscience Earnings release: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Daré Bioscience Earnings release: Q4 2023


VirtualInvestor
VirtualInvestor Jul. 14 at 7:39 PM
$DARE - Starting Soon! #DARE is about to go live during the #VirtualInvestor Closing Bell event. Hear CEO Sabrina Martucci Johnson discuss Flora Sync LF5™, the Company's strategy and future milestones, then take part in the live Q&A. Watch: https://us02web.zoom.us/webinar/register/WN_zsqyRYegSCaku_o0u3frlg#/registration
0 · Reply
VirtualInvestor
VirtualInvestor Jul. 14 at 6:08 PM
$DARE - 🔔 Tune In Today at 4 PM ET! CEO Sabrina Martucci Johnson goes live today to discuss $DARES commercial strategy and what's ahead. Stay for the live Q&A during today's #VirtualInvestor Closing Bell event. Watch here: https://us02web.zoom.us/webinar/register/WN_zsqyRYegSCaku_o0u3frlg#/registration
0 · Reply
VirtualInvestor
VirtualInvestor Jul. 13 at 8:06 PM
$DARE - Happening Tomorrow at 4 PM ET Join Daré CEO Sabrina Martucci Johnson for a Virtual Investor Closing Bell to hear about the launch of FloraSync LF5, commercial strategy, upcoming catalysts and growth plans. Register Here: https://us02web.zoom.us/webinar/register/WN_zsqyRYegSCaku_o0u3frlg#/registration
1 · Reply
SwingTraderPro1
SwingTraderPro1 Jul. 11 at 2:33 PM
Some of the biggest lessons in growth investing come from the winners you sold too early. Looking back: $AXTI - exited around $1.50 $ASYS - exited around $5 $NVTS - exited around $4 Nobody knows which small caps will become the next multibaggers until the market proves it. Now the focus shifts forward. Watching opportunities like: $DARE $SKYX Corrections often create the best setups -when fear replaces hype and quality companies become mispriced. The hunt for the next breakout opportunity continues.
0 · Reply
HMIC
HMIC Jul. 10 at 8:51 AM
1 · Reply
HMIC
HMIC Jul. 5 at 1:35 PM
$DARE Heavy insider trading.
2 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 2 at 10:03 AM
$DARE do your due dill
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 2 at 10:02 AM
$DARE yep
1 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 2 at 10:02 AM
$DARE 👍
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 2 at 10:02 AM
$DARE target here?
0 · Reply
darebio
darebio Jul. 1 at 6:24 PM
$DARE Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform https://bit.ly/4wpdmbU
0 · Reply
focafoca99
focafoca99 Jul. 1 at 1:27 PM
$DARE debuts its first consumer product, the Flora Sync LF5 vaginal probiotic. https://www.rapidticker.com/news/dare-daré-bioscience-announces-flora-sync-a7062e
0 · Reply
StackingWins999
StackingWins999 Jul. 1 at 1:15 PM
$DARE so we’re transitioning from pre revenue bio to having revenue…
2 · Reply
TheGlennSantos
TheGlennSantos Jun. 29 at 2:25 PM
$DARE Looks like it’s waking up
0 · Reply
focafoca99
focafoca99 Jun. 25 at 1:25 PM
$DARE previewed its upcoming Flora Sync LF5 launch, a first consumer health product aimed at generating revenue. https://www.rapidticker.com/news/dare-daré-bioscience-highlights-revenue-opportunity-530b4d
0 · Reply
Flypaper1
Flypaper1 Jun. 19 at 4:07 PM
$DARE we may get some good news towards the end of next week from that conference. I don’t think I’ve ever seen a weekend. Ask price this high before, good things to come?👀
1 · Reply
darebio
darebio Jun. 18 at 4:28 PM
$DARE to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026 https://ir.darebioscience.com/news-releases/news-release-details/dare-bioscience-showcase-leadership-womens-health-innovation-bio
2 · Reply
focafoca99
focafoca99 Jun. 18 at 1:30 PM
$DARE engages at BIO International Convention 2026 as CEO Sabrina Martucci Johnson presents on women’s health leadership. https://www.rapidticker.com/news/dare-daré-bioscience-to-showcase-leadership-9c94b6
0 · Reply
Jscott76
Jscott76 Jun. 16 at 8:00 PM
$DARE some fun volume towards the end!
0 · Reply
StackingWins999
StackingWins999 Jun. 12 at 9:35 PM
$DARE primed and ready to roll… 📈📈📈
2 · Reply
focafoca99
focafoca99 Jun. 12 at 8:10 PM
$DARE awarded a 1.5 million‑share increase to its 2022 Stock Incentive Plan following shareholder approval. https://www.rapidticker.com/news/dare-sec-filing-fac090
0 · Reply
Lil_Fat_Donut_Boy
Lil_Fat_Donut_Boy Jun. 11 at 3:58 PM
$DARE lost 27k on this SOB
2 · Reply